Safety and Efficacy of Aliskiren 300 mg, 150 mg and 75 mg in Patients With Essential Hypertension Compared to Ramipril 5 mg

Name: Safety and Efficacy of Aliskiren 300 mg, 150 mg and 75 mg in Patients With Essential Hypertension Compared to Ramipril 5 mg
License: Public Domain

Novartis

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

hypertension

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 391014
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.